These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 15299049

  • 1. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
    Lemke AJ, Niehues SM, Hosten N, Amthauer H, Boehmig M, Stroszczynski C, Rohlfing T, Rosewicz S, Felix R.
    J Nucl Med; 2004 Aug; 45(8):1279-86. PubMed ID: 15299049
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Aug; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE.
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
    Tsai CC, Tsai CS, Ng KK, Lai CH, Hsueh S, Kao PF, Chang TC, Hong JH, Yen TC.
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1674-83. PubMed ID: 12937950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.
    Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O.
    J Nucl Med; 2003 Aug; 44(8):1200-9. PubMed ID: 12902408
    [Abstract] [Full Text] [Related]

  • 10. PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
    Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen DT, Eikman EA, Malafa M.
    Ann Surg Oncol; 2008 Sep; 15(9):2465-71. PubMed ID: 18551347
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
    Kauhanen S, Rinta-Kiikka I, Kemppainen J, Grönroos J, Kajander S, Seppänen M, Alanen K, Gullichsen R, Nuutila P, Ovaska J.
    J Nucl Med; 2015 Aug; 56(8):1163-8. PubMed ID: 26045314
    [Abstract] [Full Text] [Related]

  • 14. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.
    Kim JH, Czernin J, Allen-Auerbach MS, Halpern BS, Fueger BJ, Hecht JR, Ratib O, Phelps ME, Weber WA.
    J Nucl Med; 2005 Apr; 46(4):587-95. PubMed ID: 15809480
    [Abstract] [Full Text] [Related]

  • 15. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
    Kuhn FP, Hüllner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, Kollias S, Veit-Haibach P.
    J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET/CT for staging of penile cancer.
    Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/CT in the evaluation of adrenal masses.
    Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E.
    J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
    [Abstract] [Full Text] [Related]

  • 18. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD.
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [Abstract] [Full Text] [Related]

  • 19. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
    Buchs NC, Bühler L, Bucher P, Willi JP, Frossard JL, Roth AD, Addeo P, Rosset A, Terraz S, Becker CD, Ratib O, Morel P.
    J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
    [Abstract] [Full Text] [Related]

  • 20. Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT.
    Slomka PJ, Dey D, Przetak C, Aladl UE, Baum RP.
    J Nucl Med; 2003 Jul; 44(7):1156-67. PubMed ID: 12843232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.